53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details

臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-005911-30-NL (EUCTR)	27/12/2022	24/10/2022	A Study of the safety and effectiveness of Efgartigimod in Patients with Primary Sjögren’s Syndrome ...	A Phase 2, Randomized, Placebo-controlled, Parallel Group, Double-blind, Proof-of-concept Study to E ...	Primary Sjögren’s Syndrome MedDRA version: 21.0;Level: LLT;Classification code 10042846;Term: Syndro ...	Product Name: efgartigimod Product Code: ARGX-113 INN or Proposed INN: Efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 2	Czechia;Hungary;Belgium;Spain;Poland;Germany;Netherlands

First Previous1Next Last